Rare Reagent Price. Within thirty (30) days after receipt of each shipment and invoice of Rare Reagents, Chiron shall pay to Gen-Probe an amount equal to [***] of the Manufacturing Cost for all Rare Reagents purchased by Chiron for use in manufacturing Initial Blood Screening Assays under Section 3.1.3(b) above. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.
Appears in 2 contracts
Samples: Agreement (Gen Probe Inc), Agreement (Gen Probe Inc)
Rare Reagent Price. Within thirty (30) days after receipt of each shipment and invoice of Rare Reagents, Chiron shall pay to Gen-Probe an amount equal to [***] of the Manufacturing Cost Costs for all Rare Reagents purchased by Chiron for use in manufacturing Initial Future Blood Screening Assays under Section 3.1.3(b3.2.4(b) above. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.
Appears in 2 contracts
Samples: Agreement (Gen Probe Inc), Agreement (Gen Probe Inc)
Rare Reagent Price. Within With respect to Rare Reagents manufactured sold by Gen-Probe to Chiron hereunder, within thirty (30) days after receipt of each shipment and invoice of Rare Reagents, Chiron shall pay to Gen-Probe an amount equal to [***] one hundred twenty percent (120%) of the Manufacturing Cost for all Rare Reagents purchased by Chiron for use in manufacturing Initial Blood Screening Exclusive Future Clinical Diagnostic Assays under Section 3.1.3(bSections 4.2.4(b) and 4.2.4(c) above. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.
Appears in 2 contracts
Samples: Agreement (Gen Probe Inc), Agreement (Gen Probe Inc)
Rare Reagent Price. Within thirty (30) days after receipt of each shipment and invoice of Rare Reagents, Chiron shall pay to Gen-Probe an amount equal to [***] one hundred twenty percent (120%) of the Manufacturing Cost for all Rare Reagents purchased by Chiron for use in manufacturing Initial Blood Screening Clinical Diagnostic Assays under Section 3.1.3(b4.1.3(b) above. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.
Appears in 2 contracts
Samples: Agreement (Gen Probe Inc), Agreement (Gen Probe Inc)
Rare Reagent Price. Within With respect to Rare Reagents sold by Gen-Probe to Chiron hereunder, within thirty (30) days after receipt of each shipment and invoice of Rare Reagents, Chiron shall pay to Gengen-Probe probe an amount equal to [***] one hundred twenty percent (120%) of the Manufacturing Cost manufacturing cost for all Rare Reagents rare reagents purchased by Chiron for use in manufacturing Initial Blood Screening nonexclusive future clinical Diagnostic Assays under Section 3.1.3(b4.3.4(a) above. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.
Appears in 2 contracts
Samples: Agreement (Gen Probe Inc), Agreement (Gen Probe Inc)
Rare Reagent Price. Within thirty (30) days after receipt of each shipment and invoice of Rare Reagents, Chiron shall pay to Gen-Probe an amount equal to [***CONFIDENTIAL TREATMENT REQUESTED] of the Manufacturing Cost Costs for all Rare Reagents purchased by Chiron for use in manufacturing Initial Future Blood Screening Assays under Section 3.1.3(b3.2.4(b) above. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.
Appears in 1 contract
Samples: Agreement (Chiron Corp)
Rare Reagent Price. Within thirty (30) days after receipt of each shipment and invoice of Rare Reagents, Chiron shall pay to Gen-Probe an amount equal to [***CONFIDENTIAL TREATMENT REQUESTED] of the Manufacturing Cost for all Rare Reagents purchased by Chiron for use in manufacturing Initial Blood Screening Assays under Section 3.1.3(b) above. *** Certain information on this page has been omitted and filed separately with the Commission. Confidential treatment has been requested with respect to the omitted portions.
Appears in 1 contract
Samples: Agreement (Chiron Corp)